Unveiling the Oral-Systemic Axis: Exploring the Role of Microbiome and Osteoimmunology in Biological Dentistry


Biological Dentistry emerges as a burgeoning field acknowledging the intricate interplay between oral well being and systemic health.

This abstract delves into the indispensable role of the microbiome and osteoimmunology as pivotal elements influencing ove rall systemic health within the domain of dentistry. Within the oral cavity resides a myriad of diverse bacteria, viruses, and fungi, comprising a staggering 700 distinct species. These microorganisms, together with their byproducts and inflammatory mediat ors, have the potential to traverse various pathways, including ingestion via saliva, thereby potentially exerting an impact on other bodily regions.

Research studies have illuminated the significance of specific bacteria, such as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, not only in causing localized oral ailments but also in bearing systemic ramifications. Porphyromonas gingivalis has been associated with gut dysbiosis, as it manages to withstand the harshness of stomach acid an d disrupts the equilibrium of the gut microbiome. Additionally, the gingipain secreted by this bacterium has been implicated in the progression of Alzheimer’s disease. Conversely, Aggregatibacter actinomycetemcomitans has been discovered to heighten the me tastatic potential of pancreatic cancer. Rather than directly causing destruction, the inflammatory response triggered by these bacteria contributes to the deterioration of tooth supporting tissues and aggravates systemic inflammation.

Osteoimmunology, th e field that studies the interaction between the immune system and bone metabolism, offers valuable insights into the intricate relationship between inflammation and bone health. Previously viewed as relatively inert, bone is now recognized as a dynamic ti ssue undergoing constant remodeling. This process is governed by diverse factors, including RANKL (receptor activator of nuclear factor kappa B ligand) and OPG (osteoprotegerin), which regulate osteoclast activity. Bacterial lipopolysaccharides, such as th ose emanating from Porphyromonas gingivalis, have been demonstrated to enhance RANKL expression in osteoblasts, leading to bone loss in periodontal disease.

Appreciating these complex connections between oral health, the microbiome, osteoimmunology, and s ystemic health is of paramount significance within the realm of biological dentistry. By acknowledging the influence of oral pathogens and inflammation on systemic well being, a comprehensive approach can be embraced to foster both oral and overall health.

In the pursuit of enhancing osseointegration and implant stability, a pilot study was conducted utilizing a unique Ion Induction Therapy (IIT) protocol, along with IV Ozone. Preliminary results showcased remarkable outcomes, with Osstell ISQ scores avera ging 72 after 16 weeks post op. This data presents a notable advantage over a comparable study by Vladimir Kokovic et al., which achieved an average ISQ value of 64 for the same type of implant. Notably, ISQ scores above 70 indicate high stability, 60 69 s ignify medium stability, and scores below 60 denote low stability. This promising integration of IIT and IV Ozone highlights the potential to elevate osseointegration, thereby underlining the practical impact of these interventions in the realm of biologic al dentistry.

Further exploration through research endeavors and clinical investigations is warranted to advance our comprehension and devise effective strategies in biological dentistry, ultimately enhancing patient outcomes and systemic well being.

Author:
Dr. med. dent. Sebastjan Perko, Phd.
dr.perko@maha.si www.maha.si

References:
• Abou-Khalil, R., Yang, F., & Lieu, S. (2013). Regulation of osteogenesis and bone remodeling by hedgehog signaling. Connective Tissue Research, 54(5), 373-378.
• Alvarez, C., Monasterio, G., Cavalla, F., Córdova, L. A., Hernández, M., Heymann, D., Garlet, G. P., Sorsa, T., Pärnänen, P., Lee, H. M., Golub, L. M., Vernal, R., & Kantarci, A. (2019). Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms. Frontiers in Immunology
• Boyce, B. F., & Xing, L. (2008). Biology of RANK, RANKL, and osteoprotegerin. Arthritis Research & Therapy, 9(Suppl 1), S1.
• Chow, S. K. H., Leung, K. S., & Qin, J. (2019). Treatment of osteoporosis with electric and electromagnetic fields. Journal of Osteoporosis, 2019, 7539162.
• Ciancaglini, R., Radaelli, G., & Pagani, S. (1999). Association of temporomandibular disorder symptoms with anxiety and depression in the general Italian population. Journal of Oral Rehabilitation, 26(1), 52-59.
• Grgič, V., Karba, R., & Brilej, D. (2019). Pulsed electromagnetic field therapy in the treatment of pain and other symptoms in fibromyalgia: A randomized controlled study. Bioelectromagnetics, 40(5), 351-360.
• Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., Xu, J., & Zheng, M. H. (2015). Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Research, 3, 15022.
• Hak, D. J., & Fitzsimmons, R. J. (2017). Orthopedic implications for osteoporosis. In Osteoporosis in Orthopedics (pp. 13-18). Springer, Cham.
• Ju, C., & Tacke, F. (2016). Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cellular and Molecular Immunology, 13(3), 316- 327.
• Kokovic, V., Rahman, M., Rahman, B., & Tattan, M. (2015). Assessment of Implant Stability of Two-piece Zirconium Dioxide Implants using Resonance Frequency Analysis: A Pilot Study.
• Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., … & Kostenuik, P. J. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and
activation. Cell, 93(2), 165-176.
• Manolagas, S. C. (2010). From estrogen-centric to aging and oxidative stress: A revised
perspective of the pathogenesis of osteoporosis. Endocrine Reviews, 31(3), 266-300.
• Papageorgiou, S. N., Papadopoulos, M. A., & Katsarou, Z. (2008). Osteoimmunology: The role of the immune system in bone metabolism and disease. Critical ReviewsTM in Immunology,
28(3), 239-262.
• Pufe, T., Lemke, A., Kurz, B., Petersen, W., & Tillmann, B. (2001). Mechanical overload
induces VEGF in cartilage discs via hypoxia-inducible factor. American Journal of Pathology,
158(1), 185-192.
• Rauner, M., & Hofbauer, L. C. (2007). Mode of action of bisphosphonates: Nitrogen-containing
bisphosphonates induce osteoblast apoptosis in vitro. Bone, 40(3), 904-910.
• Ritz, U., Gerke, V., & Vincenz, C. (2012). Osteopontin functionally activates solid tumor cell growth, intratumoral macrophages, and vascular cells: A novel pathway potentially involved in
osteosarcoma tumor progression. Cancer Research, 72(1), 146-156.

• Rossini, M., Adami, G., Adami, S., Viapiana, O., & Gatti, D. (2018). Safety and efficacy of tibolone in postmenopausal women: A comprehensive review. Expert Opinion on Drug Safety, 17(8), 787-796.
• Rucci, N., & Teti, A. (2010). Osteomimicry: How tumor cells try to deceive the bone. Frontiers in Bioscience (Scholar Edition), 2, 907-915.
• Suda, T., Takahashi, N., & Udagawa, N. (1999). Acidic microenvironment and bone resorption. In Seminars in Immunology (Vol. 11, No. 3, pp. 175-183). Academic Press.
• Szentpétery, A., & Hofbauer, L. C. (2015). Highlights in bone and cartilage research: Update 2015. Immune-bone interactions. Osteoporosis International, 26(3), 677-682.
• Tan, C., Liu, Y., Li, W., & Li, D. (2017). Osteoblast: Functions, differentiation, and bone development. In Stem Cells in Craniofacial Development and Regeneration (pp. 1-36). Springer, Cham.
• Tanaka, Y., Tanaka, R., Miyake, Y., Kanazawa, I., Tanaka, K., Sunaga, M., … & Yamaguchi, T. (2016). Ibandronate suppresses osteoclastic and osteoblastic changes in the bone marrow of rheumatoid arthritis model mice treated with prednisolone. Arthritis Research & Therapy, 18(1), 1-12.
• Wang, L., Wang, Y., Han, Y., & Zhang, G. (2015). Osteoblast-derived PGE2 promotes pannexin1-mediated MSC osteogenic differentiation via the GSK3β/β-catenin signaling pathway. Journal of Cell Science, 128(22), 4317-4327.
• Yavropoulou, M. P., van Lierop, A. H., & Hamdy, N. A. (2014). Osteoimmunology: The hidden immune regulation of bone metabolism. Endocrine Reviews, 35(3), 458-488.
• Zhang, J., Tanaka, H., Chigusa, M., Nagata, K., & Kawamura, Y. (2018). Quantitative analysis of multi-mechanistic effects of extremely low frequency magnetic fields on gene expression levels in human dermal fibroblasts. Journal of Radiation Research, 59(3), 325-336.